Probiotic Use in Patients With Prior COPD Exacerbation



Status:Not yet recruiting
Conditions:Chronic Obstructive Pulmonary Disease, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:2/8/2015
Start Date:October 2014
End Date:December 2016
Contact:Karen S Allen, MD
Email:karen-allen@ouhsc.edu
Phone:405-271-6173

Use our guide to learn which trials are right for you!

The purpose of the study is to examine the hypothesis test that probiotics will reduce the
frequency of exacerbation in patients with COPD.


Inclusion Criteria:

1. Patients admitted to OUMC or VAMC with a COPD exacerbation and pneumonia with
underlying COPD will be eligible and screened.

2. Patients seen in VA Chest Medicine clinic, OU Physicians clinic and Pulmonary fellows
clinic at PPOB who have had a COPD exacerbation within the last year.

3. Patients over age 18

4. Patients who have a pulmonary function test (PFT) showing COPD within 1 year of
enrollment in the study or if the treating physician plans to obtain PFT as part of
the patient's care plan.

5. Patients will be considered to have a diagnosis of COPD if they have a FEV1 of less
than 80% of predicted and a FVC/FEV1 ratio of less than 0.70 (as defined by GOLD
criteria).

Exclusion Criteria:

1. Patients with less than one year of life expectancy from a concomitant diagnosis

2. Any GI motility disorders or previous bowel resection surgery (short gut syndrome)

3. Any patients with decreased immune function or on medication that may decrease immune
function (other than low dose steroid or steroid taper).

4. Patients admitted within the last one year with a diagnosis of pancreatitis

5. Patients unable to give consent will not be included in the study.

6. Patients unable to sign consent

7. Patients already on azithromycin daily for COPD exacerbations

8. Patients under department of corrections custody.
We found this trial at
1
site
Oklahoma City, Oklahoma 73190
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials